# 2026-12239: FDA Seeks Comments on Animal Drug Paperwork Again

2026-12239, Agency Information Collection Activities; Proposed Collection; Comment Request; Extralabel Drug Use in Animals, is a Federal Register notice from Health and Human Services Department, Food and Drug Administration published 2026-06-18, effective Either electronic or written comments on the collection of information must be submitted by August 17, 2026.; PRIA reads it as touching household money (as of 2026-06-25).

- Canonical: https://policyrisk.com/federal-register/2026-12239
- As of: 2026-06-25
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-12239
- Title: Agency Information Collection Activities; Proposed Collection; Comment Request; Extralabel Drug Use in Animals
- Type: Notice
- Agencies: Health and Human Services Department; Food and Drug Administration
- Citation: 91 FR 36868
- Published: 2026-06-18
- Effective: Either electronic or written comments on the collection of information must be submitted by August 17, 2026.
- Comments close: 2026-08-17
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-06-25

## In one line

FDA Seeks Comments on Animal Drug Paperwork Again

## Summary

The FDA wants your thoughts on how they collect info about using drugs in animals in ways not originally approved (called extralabel use). This affects vets, farmers, and animal drug makers who report this info. You’ve got until August 17, 2026, to share your comments—no cost changes, just making sure the paperwork is clear and easy.

## Abstract

The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the reporting requirements associated with extralabel drug use in animals.

## Effects PRIA read

- Potential Method Development: 4,160-hour Burden: cost, high. FDA may require analytical methods to detect residues from extralabel use of animal drugs under 21 CFR 530.22(b). FDA estimates up to two methods could be required each year, with an average burden of 4,160 hours per response and a total estimated 8,320 hours annually; comments are due by August 17…

## Related documents

- [2026-16296](https://policyrisk.com/federal-register/2026-16296): Substances Generally Recognized as Safe, 2026-08-11
- [2026-14073](https://policyrisk.com/federal-register/2026-14073): Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign E…, 2026-07-13
- [2026-13047](https://policyrisk.com/federal-register/2026-13047): Establishment Registration and Product Listing for Tobacco Products, 2026-06-29
- [2025-04978](https://policyrisk.com/federal-register/2025-04978): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-03-25
- [2025-01840](https://policyrisk.com/federal-register/2025-01840): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-01-27
- [2026-20727](https://policyrisk.com/federal-register/2026-20727): Medical Devices; Immunology and Microbiology Devices; Classification of the System for Detection of Nucleic Acid From Non-Viral Microorgani…, 2026-10-09

## Sources
- [2026-12239 on federalregister.gov](https://www.federalregister.gov/documents/2026/06/18/2026-12239/agency-information-collection-activities-proposed-collection-comment-request-extralabel-drug-use-in)
- [2026-12239 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-06-18/pdf/2026-12239.pdf)

## Related
- [Previous: 2026-12238, Agency Information Collection Activities; Submission for Office of Management a…](https://policyrisk.com/federal-register/2026-12238)
- [Next: 2026-12240, Request for Information Regarding Products and Categories of Products Used in H…](https://policyrisk.com/federal-register/2026-12240)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-12239 (as of 2026-06-25).